Elizabeth Castro Moreno

Elizabeth Castro Moreno

Auto-generated profile, based on publicly available information

Elizabeth Castro Moreno

Federal University of Minas Gerais, Belo Horizonte, MG, Brazil

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2010 in BMC Immunology
Verified
Journal Article
Open access
PDF file
LFLucia Fraga
Lucia Fraga
ELErika W Lamb
Erika W Lamb
EMElizabeth C Moreno
Elizabeth C Moreno
MCMitali Chatterjee
Mitali Chatterjee
JDJan Dvořák
Jan Dvořák
SDStephen J Davies
Stephen J Davies
Background: During the pre-patent stage of infection, juvenileSchistosomablood flukes co-opt signals from the adaptive immune system to facilitate parasite development, but the types of responses that are induced at this early stage of infection, and the parasite antigens they target, have not been characterized.Results: Through analysis of experimental pre-patent infections, we show that theS. mansonicysteine protease SmCB1 is rapidly targeted by an antigen-specific IgE response. The induction of this response is independent of schistosome eggs as infection with male or female worms alone also induced SmCB1-specific IgE. We also show that the SmCB1-specific IgE response is dependent on cognate CD4+T cell help and IL-4, suggesting that pre-patent Th2 responses provide T cell help for the SmCB1-specific IgE response. Finally, exposed human subjects also produced IgE against SmCB1.Conclusions: Our data demonstrate that, like eggs, schistosome worms also induce functional type 2 responses and that a parasite cysteine protease is an inducer of type 2 responses during the early stages of schistosome infection.

20 October 2009 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
EMElizabeth Castro Moreno
Elizabeth Castro Moreno
AGAndréa Vieira Gonçalves
Andréa Vieira Gonçalves
ACAnderson Vieira Chaves
Anderson Vieira Chaves
MMMaria Norma Melo
Maria Norma Melo
JLJosé Roberto Lambertucci
José Roberto Lambertucci
MCMariângela Carneiro
Mariângela Carneiro
One of the most important drawbacks in visceral leishmaniasis (VL) population studies is the difficulty of diagnosing asymptomatic carriers. The aim of this study, conducted in an urban area in the Southeast of Brazil, was to evaluate the performance of serology to identify asymptomatic VL infection in participants selected from a cohort with a two-year follow-up period. Blood samples were collected in 2001 from 136 cohort participants (97 positive and 39 negatives, PCR/hybridization carried out in 1999). They were clinically evaluated and none had progressed to disease from their asymptomatic state. As controls, blood samples from 22 control individuals and 8 patients with kala-azar were collected. Two molecular biology techniques (reference tests) were performed: PCR with Leishmania-generic primer followed by hybridization using L. infantum probe, and PCR with specific primer to L. donovani complex. Plasma samples were tested by ELISA using three different antigens: L. infantum and L. amazonensis crude antigens, and rK39 recombinant protein. Accuracy of the serological tests was evaluated using sensitivity, specificity, likelihood ratio and ROC curve. The presence of Leishmania was confirmed, by molecular techniques, in all kala-azar patients and in 117 (86%) of the 136 cohort participants. Kala-azar patients showed high reactivity in ELISAs, whereas asymptomatic individuals presented low reactivity against the antigens tested. When compared to molecular techniques, the L. amazonensis and L. infantum antigens showed higher sensitivity (49.6% and 41.0%, respectively) than rK39 (26.5%); however, the specificity of rK39 was higher (73.7%) than L. amazonensis (52.6%) and L. infantum antigens (36.8%). Moreover, there was low agreement among the different antigens used (kappa<0.10). Serological tests were inaccurate for diagnosing asymptomatic infections compared to molecular methods; this could lead to misclassification bias in population studies. Therefore, studies which have used serological assays to estimate prevalence, to evaluate intervention programs or to identify risk factors for Leishmania infection, may have had their results compromised. Visceral leishmaniasis or kala-azar in Brazil, caused by a parasite protozoon, is transmitted to humans by sandflies and has wild and domestic dogs as reservoirs. The disease can become chronic, characterized by fever, weight loss, and enlargement of the liver and spleen. However, the infection in humans can be asymptomatic, and the importance of this phase is unknown. The low levels of immune response and the small number of circulating parasites in the blood are the main problems in identifying the asymptomatic phase. In this study we evaluated the performance of the serology tests compared with molecular tests to identify asymptomatic infection in individuals identified in an urban area of Brazil. Also included were non-infected individuals (healthy controls) and patients (diseased controls). Blood was collected and examined by different serological methods and compared with molecular techniques. The presence of the parasite was confirmed by all molecular techniques and should be the method used to identify true infection. The serology methods showed low sensitivity in detecting the infection. We concluded that the serologic methods are inaccurate in identifying asymptomatic infection when compared to molecular techniques and could underestimate the infection in population studies.

24 September 2012 in Transfusion
Verified
Journal Article
Closed access
PDF file
TGThelma T. Gonçalez
Thelma T. Gonçalez
COClaudia Di Lorenzo Oliveira
Claudia Di Lorenzo Oliveira
ACAnna Barbara F. Carneiro‐Proietti
Anna Barbara F. Carneiro‐Proietti
EMElizabeth C. Moreno
Elizabeth C. Moreno
CMCarolina Miranda
Carolina Miranda
NCNHLBI Retrovirus Epidemiology Donor Study‐II (REDS‐II), International Component
NHLBI Retrovirus Epidemiology Donor Study‐II (REDS‐II), International Component

4 July 2016 in Virology Journal
Verified
Journal Article
Open access
PDF file
GCGalileu Barbosa Costa
Galileu Barbosa Costa
LALídia Teodoro Santos Augusto
Lídia Teodoro Santos Augusto
JLJuliana Leite
Juliana Leite
PFPaulo César Peregrino Ferreira
Paulo César Peregrino Ferreira
CBCláudio Bonjardim
Cláudio Bonjardim
GTGiliane Trindade
Giliane Trindade
Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus, a virus from Orthopoxvirus genus (OPV) that affects mainly cattle herds and humans in rural areas in Brazil. Because most studies have focused on outbreaks situations, data on BV epidemiology is limited. A cross sectional study in Brazilian rural areas during 2012–2013 was conducted to determine the neutralizing antibodies seroprevalence and risk factors for BV. A structured questionnaire was applied to elicit demographics data and farming practices considered risk factors for BV exposure. Neutralizing anti-OPV antibodies were investigated using plaque reduction neutralization test. The neutralizing antibodies prevalence rates were calculated and the risk factor analysis was performed using multivariate logistic regression. Two hundred and forty participants were enrolled in this study with a prevalence of neutralizing antibodies of 30.8 % (95 % confidence interval [CI], 25.3–36.9). In multivariate analysis, age > 35 years (Odds Ratio [OR] = 18.2; CI 95 % = 7.7 – 43.2) and previous outbreak in property (OR = 3.9; C I95 % = 1.2 – 12.6) were independently associated with anti-OPV neutralizing antibodies. In this study, anti-OPV protective immunity (neutralizing antibody titers) was assessed in an endemic BV Brazilian rural area. Our findings indicate that epidemiological surveillance is required and should be applied by public health authorities to create interventions and/or prevention strategies to avoid viral spread causing future outbreaks among individuals who are under risk of infection.

1 December 2015 in Emerging Infectious Diseases
Verified
Journal Article
Open access
GCGalileu Barbosa Costa
Galileu Barbosa Costa
IBIara A. Borges
Iara A. Borges
PAPedro Alves
Pedro Alves
JMJúlia B. Miranda
Júlia B. Miranda
ALAna Paula M.F. Luiz
Ana Paula M.F. Luiz
GTGiliane Trindade
Giliane Trindade

29 February 2016 in Transfusion Medicine
Verified
Journal Article
Closed access
PDF file
EME. C. Moreno
E. C. Moreno
EBE. Bolina‐Santos
E. Bolina‐Santos
FMF. Mendes‐Oliveira
F. Mendes‐Oliveira
CMC. Miranda
C. Miranda
ESEster Cerdeira Sabino
Ester Cerdeira Sabino
ACA. B. de Freitas Carneiro‐Proietti1
A. B. de Freitas Carneiro‐Proietti1